Assertio Holdings Résultats passés
Passé contrôle des critères 0/6
Les bénéfices de Assertio Holdings ont diminué à un taux annuel moyen de -18.6%, tandis que le secteur Pharmaceuticals a vu ses bénéfices augmenter de en à 9.1% par an. Les revenus ont augmenté de en baisse à un taux moyen de 0.3% par an.
Informations clés
-18.61%
Taux de croissance des bénéfices
-7.93%
Taux de croissance du BPA
| Pharmaceuticals Croissance de l'industrie | 5.95% |
| Taux de croissance des recettes | -0.30% |
| Rendement des fonds propres | -47.19% |
| Marge nette | -34.94% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour du récit • May 03
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.Mise à jour du récit • Apr 19
ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.
Mise à jour du récit • Apr 04
ASRT: Reverse Split And 2026 Guidance Will Shape Future Upside Potential
Analysts have kept Assertio Holdings' fair value estimate steady at $28.00, while modestly refining their assumptions around revenue growth, profit margins, and future P/E. This has led to a recalibrated price target that they see as better aligned with updated fundamentals.Mise à jour du récit • Mar 21
ASRT: Reverse Split And 2026 Guidance Will Reshape Risk Reward Profile
Analysts have raised their price target on Assertio Holdings from $1.75 to $28.00, citing updated assumptions for revenue growth, profit margins, discount rate, and a lower future P/E multiple in their models. Analyst Commentary Even with a sharply higher price target in some models, not all research views point in the same direction for Assertio Holdings.Mise à jour du récit • Mar 07
ASRT: Reverse Split And Earnings Power Will Support Rerating Potential
Analysts have raised their price target on Assertio Holdings, maintaining the figure at $37.44, while citing updated views on fair value, discount rate, revenue growth, profit margin and future P/E as the reasons for the revised assessment. Analyst Commentary Bullish Takeaways Bullish analysts view the reaffirmed $37.44 price target as consistent with their updated fair value work, suggesting the current share price still leaves room for upside if execution tracks their assumptions.
Mise à jour du récit • Feb 21
ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have revised their price target for Assertio Holdings to $45.00. The update reflects slightly adjusted assumptions around discount rate, revenue growth, profit margin and future P/E expectations.Article d’analyse • Feb 07
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders would be excited to see that the share price has had a great...Mise à jour du récit • Feb 07
ASRT: Reverse Split And Earnings Visibility Will Reframe Risk Reward Profile
Analysts have modestly adjusted their price target for Assertio Holdings, citing updated views on discount rates, long term revenue trends and sustainable profit margins, along with a slightly higher assumed future P/E multiple. Analyst Commentary Recent Street research on a comparable operator in the transport and infrastructure space, Asur, offers a useful reference point for how analysts are currently weighing valuation against execution risk when traffic and revenue visibility are in focus.Mise à jour du récit • Jan 24
ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have trimmed their price target on Assertio Holdings to $45.00 from $44.99, reflecting updated assumptions that indicate a smaller revenue decline, higher profit margins near 15%, and a lower future P/E closer to 16x. Analyst Commentary Bullish analysts in the wider market are pointing to companies that maintain or improve profitability targets and trade on mid-teens P/E multiples as potential opportunities for re-rating when execution holds up.Mise à jour du récit • Jan 10
ASRT: Reverse Split And New Leadership Will Reframe Risk Reward Profile
Analysts lifted their fair value estimate for Assertio Holdings from $2.69 to $37.44, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E as the key drivers of the new price target range. Analyst Commentary Recent Street research on airport operators with similar business profiles offers some context for how analysts might be thinking about Assertio Holdings, particularly around traffic trends, valuation ranges, and the balance between upside potential and execution risk.Mise à jour du récit • Dec 26
ASRT Will Rely On Cost Discipline To Support Future Upside Potential
Analysts have raised their price target on Assertio Holdings significantly, from approximately $3.00 to about $45.00. This reflects a higher assumed fair value multiple despite more conservative expectations for revenue growth and profit margins.Article d’analyse • Dec 24
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Lagging The Industry But So Is The Business
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy...Article d’analyse • Sep 18
Is Assertio Holdings (NASDAQ:ASRT) Using Debt In A Risky Way?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Article d’analyse • May 15
Assertio Holdings, Inc. (NASDAQ:ASRT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Assertio Holdings, Inc. ( NASDAQ:ASRT ) missed earnings with its latest first-quarter results, disappointing...Article d’analyse • Apr 30
Is Assertio Holdings (NASDAQ:ASRT) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Nouveau récit • Apr 28
Rolvedon And Sympazan Will Create New Market Opportunities
Strategic market penetration and increased commercial efforts for Rolvedon and Sympazan aim to boost revenue growth.Article d’analyse • Mar 14
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues Are Not Doing Enough For Some Investors
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.6x might make it look like a strong buy...Article d’analyse • Dec 24
Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d’analyse • Nov 15
Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders that were waiting for something to happen have been dealt a blow...Article d’analyse • Sep 25
Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Aug 19
Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have retraced a considerable 30% in the last month, reversing a fair...Article d’analyse • Jul 04
There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 36...Article d’analyse • May 07
Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 29...Article d’analyse • Apr 18
Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Article d’analyse • Mar 13
Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders are no doubt pleased to see that the share price has bounced 26...Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Assertio Holdings gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 102 | -36 | 66 | 2 |
| 31 Dec 25 | 119 | -30 | 69 | 2 |
| 30 Sep 25 | 137 | -29 | 77 | 2 |
| 30 Jun 25 | 117 | -43 | 78 | 3 |
| 31 Mar 25 | 119 | -31 | 80 | 4 |
| 31 Dec 24 | 125 | -22 | 75 | 4 |
| 30 Sep 24 | 126 | -68 | 77 | 4 |
| 30 Jun 24 | 132 | -345 | 79 | 4 |
| 31 Mar 24 | 142 | -333 | 71 | 4 |
| 31 Dec 23 | 152 | -332 | 70 | 3 |
| 30 Sep 23 | 169 | -186 | 60 | 2 |
| 30 Jun 23 | 168 | 98 | 55 | 1 |
| 31 Mar 23 | 162 | 97 | 55 | 0 |
| 31 Dec 22 | 156 | 110 | 48 | 0 |
| 30 Sep 22 | 139 | 26 | 35 | 0 |
| 30 Jun 22 | 130 | 25 | 41 | 0 |
| 31 Mar 22 | 121 | 3 | 43 | 0 |
| 31 Dec 21 | 111 | -1 | 46 | 0 |
| 30 Sep 21 | 110 | -30 | 69 | 0 |
| 30 Jun 21 | 119 | -44 | 75 | 2 |
| 31 Mar 21 | 114 | -65 | 90 | 3 |
| 31 Dec 20 | 108 | -28 | 104 | 4 |
| 30 Sep 20 | 135 | -196 | 106 | 10 |
| 30 Jun 20 | 156 | -183 | 116 | 10 |
| 31 Mar 20 | 192 | -162 | 113 | 9 |
| 31 Dec 19 | 230 | -217 | 110 | 10 |
| 30 Sep 19 | 157 | -49 | 111 | 7 |
| 30 Jun 19 | 180 | -4 | 108 | 7 |
| 31 Mar 19 | 186 | -11 | 116 | 8 |
| 31 Dec 18 | 256 | 37 | 120 | 8 |
| 30 Sep 18 | 364 | 28 | 143 | 7 |
| 30 Jun 18 | 381 | -36 | 160 | 7 |
| 31 Mar 18 | 419 | -42 | 179 | 10 |
| 31 Dec 17 | 381 | -102 | 203 | 14 |
| 30 Sep 17 | 410 | -114 | 203 | 22 |
| 30 Jun 17 | 425 | -111 | 205 | 30 |
| 31 Mar 17 | 442 | -95 | 206 | 32 |
| 31 Dec 16 | 456 | -89 | 205 | 33 |
| 30 Sep 16 | 443 | -75 | 194 | 30 |
| 30 Jun 16 | 437 | -74 | 192 | 24 |
| 31 Mar 16 | 415 | -85 | 197 | 22 |
| 31 Dec 15 | 343 | -76 | 179 | 18 |
| 30 Sep 15 | 426 | 50 | 170 | 13 |
| 30 Jun 15 | 373 | 68 | 148 | 10 |
Des revenus de qualité: ASRT n'est actuellement pas rentable.
Augmentation de la marge bénéficiaire: ASRT n'est actuellement pas rentable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: ASRT n'est pas rentable et les pertes ont augmenté au cours des 5 dernières années à un rythme de 18.6% par an.
Accélération de la croissance: Impossible de comparer la croissance des bénéfices de ASRT au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable
Bénéfices par rapport au secteur d'activité: ASRT n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Pharmaceuticals ( -5% ).
Rendement des fonds propres
ROE élevé: ASRT a un retour sur capitaux propres négatif ( -47.19% ), car il n'est actuellement pas rentable.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/17 06:56 |
| Cours de l'action en fin de journée | 2026/05/15 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Assertio Holdings, Inc. est couverte par 18 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Scott Henry | Alliance Global Partners |
| null null | Argus Research Company |
| Kenneth Trbovich | Brean Capital Historical (Janney Montgomery) |